Anne-Julie Cloux - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Anne-Julie Cloux

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Revue Medicale Suisse|November 27, 2025

Anne-Julie Cloux

Revue Medicale Suisse|June 26, 2026

[Health, gender, and migration : intersectionality as an analytical framework]Claudia Truppa, Laura Mellini, Lori Ducroz-Lelevrier, et al.

Autophagy|February 4, 2014

A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesisVanessa Ginet, Julien Puyal, Coralie Rummel, et al.

Oncotarget|December 6, 2019

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agentAnne-Julie Cloux, Dominique Aubry, Mathieu Heulot, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Revue Medicale Suisse|November 27, 2025

Anne-Julie Cloux

Revue Medicale Suisse|June 26, 2026

[Health, gender, and migration : intersectionality as an analytical framework]Claudia Truppa, Laura Mellini, Lori Ducroz-Lelevrier, et al.

Autophagy|February 4, 2014

A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesisVanessa Ginet, Julien Puyal, Coralie Rummel, et al.

Oncotarget|December 6, 2019

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agentAnne-Julie Cloux, Dominique Aubry, Mathieu Heulot, et al.

Pageof 1